US Stock MarketDetailed Quotes

Abbott Laboratories (ABT)

Watchlist
  • 123.530
  • -0.840-0.68%
Close Jan 15 16:00 ET
  • 123.300
  • -0.230-0.19%
Post 20:01 ET
214.80BMarket Cap15.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Abbott Laboratories (ABT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
6.90%11.37B
7.37%11.14B
3.95%10.36B
4.59%41.95B
7.16%10.97B
4.85%10.64B
4.00%10.38B
2.23%9.96B
-8.12%40.11B
1.49%10.24B
Operating revenue
6.90%11.37B
7.37%11.14B
3.95%10.36B
4.59%41.95B
7.16%10.97B
4.85%10.64B
4.00%10.38B
2.23%9.96B
-8.12%40.11B
1.49%10.24B
Cost of revenue
8.02%5.08B
5.45%4.85B
0.11%4.47B
4.07%18.71B
8.47%4.94B
2.02%4.7B
2.68%4.6B
3.05%4.46B
-6.10%17.98B
-0.81%4.56B
Gross profit
6.01%6.29B
8.90%6.29B
7.07%5.89B
5.01%23.24B
6.10%6.03B
7.20%5.94B
5.08%5.77B
1.57%5.5B
-9.70%22.13B
3.40%5.69B
Operating expense
3.90%4.24B
3.19%4.24B
1.99%4.2B
4.87%16.42B
5.53%4.12B
4.81%4.08B
3.85%4.11B
5.32%4.12B
-3.05%15.66B
-6.89%3.91B
Selling and administrative expenses
5.39%3.05B
5.28%3.09B
3.45%3.06B
6.83%11.7B
6.72%2.91B
6.32%2.9B
7.15%2.94B
7.13%2.96B
-2.66%10.95B
-8.38%2.72B
Research and development costs
7.43%766M
3.87%725M
4.68%716M
3.76%2.84B
7.00%749M
6.10%713M
-2.38%698M
4.59%684M
-5.09%2.74B
-3.45%700M
Depreciation amortization depletion
-10.64%420M
-10.83%420M
-11.02%420M
-4.48%1.88B
-3.33%465M
-5.24%470M
-5.42%471M
-3.87%472M
-2.33%1.97B
-3.02%481M
-Depreciation and amortization
-10.64%420M
-10.83%420M
-11.02%420M
-4.48%1.88B
-3.33%465M
-5.24%470M
-5.42%471M
-3.87%472M
-2.33%1.97B
-3.02%481M
Operating profit
10.65%2.06B
22.95%2.05B
22.15%1.69B
5.36%6.83B
7.36%1.91B
12.87%1.86B
8.24%1.67B
-8.15%1.39B
-22.53%6.48B
36.50%1.78B
Net non-operating interest income expense
13.73%-44M
13.79%-50M
19.67%-49M
14.68%-215M
35.71%-45M
26.09%-51M
4.92%-58M
-17.31%-61M
32.80%-252M
-6.06%-70M
Non-operating interest income
-15.38%77M
-13.41%71M
2.50%82M
-10.65%344M
2.25%91M
-6.19%91M
-16.33%82M
-20.79%80M
110.38%385M
1.14%89M
Non-operating interest expense
-14.79%121M
-13.57%121M
-7.09%131M
-12.24%559M
-14.47%136M
-14.46%142M
-11.95%140M
-7.84%141M
14.16%637M
3.25%159M
Other net income (expense)
26.52%167M
3,800.00%148M
20.72%134M
-7.99%403M
92.94%164M
41.94%132M
-102.58%-4M
5.71%111M
37.30%438M
3.66%85M
Gain on sale of security
54.55%17M
83.33%11M
--7M
165.85%27M
141.67%10M
10.00%11M
128.57%6M
----
-1,950.00%-41M
-271.43%-24M
Other non- operating income (expenses)
23.97%150M
1,470.00%137M
14.41%127M
-21.50%376M
41.28%154M
45.78%121M
-105.68%-10M
0.00%111M
49.22%479M
60.29%109M
Income before tax
12.37%2.18B
33.79%2.15B
23.82%1.78B
5.24%7.01B
13.09%2.03B
16.10%1.94B
-1.77%1.61B
-8.07%1.44B
-19.77%6.66B
35.98%1.8B
Income tax
82.31%536M
21.64%371M
114.69%453M
-778.96%-6.39B
-3,681.59%-7.2B
25.11%294M
16.86%305M
-13.52%211M
-31.46%941M
-29.97%201M
Net income
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
Net income continuous Operations
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
Minority interest income
Net income attributable to the parent company
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
Basic earnings per share
0.00%0.94
37.84%1.02
8.57%0.76
133.84%7.67
479.78%5.3295
14.63%0.94
-6.33%0.74
-6.67%0.7
-16.75%3.28
54.64%0.9192
Diluted earnings per share
0.00%0.94
36.49%1.01
8.57%0.76
134.36%7.64
479.12%5.27
14.63%0.94
-5.13%0.74
-6.67%0.7
-16.62%3.26
54.24%0.91
Dividend per share
7.27%0.59
7.27%0.59
7.27%0.59
7.84%2.2
7.84%0.55
7.84%0.55
7.84%0.55
7.84%0.55
8.51%2.04
8.51%0.51
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 6.90%11.37B7.37%11.14B3.95%10.36B4.59%41.95B7.16%10.97B4.85%10.64B4.00%10.38B2.23%9.96B-8.12%40.11B1.49%10.24B
Operating revenue 6.90%11.37B7.37%11.14B3.95%10.36B4.59%41.95B7.16%10.97B4.85%10.64B4.00%10.38B2.23%9.96B-8.12%40.11B1.49%10.24B
Cost of revenue 8.02%5.08B5.45%4.85B0.11%4.47B4.07%18.71B8.47%4.94B2.02%4.7B2.68%4.6B3.05%4.46B-6.10%17.98B-0.81%4.56B
Gross profit 6.01%6.29B8.90%6.29B7.07%5.89B5.01%23.24B6.10%6.03B7.20%5.94B5.08%5.77B1.57%5.5B-9.70%22.13B3.40%5.69B
Operating expense 3.90%4.24B3.19%4.24B1.99%4.2B4.87%16.42B5.53%4.12B4.81%4.08B3.85%4.11B5.32%4.12B-3.05%15.66B-6.89%3.91B
Selling and administrative expenses 5.39%3.05B5.28%3.09B3.45%3.06B6.83%11.7B6.72%2.91B6.32%2.9B7.15%2.94B7.13%2.96B-2.66%10.95B-8.38%2.72B
Research and development costs 7.43%766M3.87%725M4.68%716M3.76%2.84B7.00%749M6.10%713M-2.38%698M4.59%684M-5.09%2.74B-3.45%700M
Depreciation amortization depletion -10.64%420M-10.83%420M-11.02%420M-4.48%1.88B-3.33%465M-5.24%470M-5.42%471M-3.87%472M-2.33%1.97B-3.02%481M
-Depreciation and amortization -10.64%420M-10.83%420M-11.02%420M-4.48%1.88B-3.33%465M-5.24%470M-5.42%471M-3.87%472M-2.33%1.97B-3.02%481M
Operating profit 10.65%2.06B22.95%2.05B22.15%1.69B5.36%6.83B7.36%1.91B12.87%1.86B8.24%1.67B-8.15%1.39B-22.53%6.48B36.50%1.78B
Net non-operating interest income expense 13.73%-44M13.79%-50M19.67%-49M14.68%-215M35.71%-45M26.09%-51M4.92%-58M-17.31%-61M32.80%-252M-6.06%-70M
Non-operating interest income -15.38%77M-13.41%71M2.50%82M-10.65%344M2.25%91M-6.19%91M-16.33%82M-20.79%80M110.38%385M1.14%89M
Non-operating interest expense -14.79%121M-13.57%121M-7.09%131M-12.24%559M-14.47%136M-14.46%142M-11.95%140M-7.84%141M14.16%637M3.25%159M
Other net income (expense) 26.52%167M3,800.00%148M20.72%134M-7.99%403M92.94%164M41.94%132M-102.58%-4M5.71%111M37.30%438M3.66%85M
Gain on sale of security 54.55%17M83.33%11M--7M165.85%27M141.67%10M10.00%11M128.57%6M-----1,950.00%-41M-271.43%-24M
Other non- operating income (expenses) 23.97%150M1,470.00%137M14.41%127M-21.50%376M41.28%154M45.78%121M-105.68%-10M0.00%111M49.22%479M60.29%109M
Income before tax 12.37%2.18B33.79%2.15B23.82%1.78B5.24%7.01B13.09%2.03B16.10%1.94B-1.77%1.61B-8.07%1.44B-19.77%6.66B35.98%1.8B
Income tax 82.31%536M21.64%371M114.69%453M-778.96%-6.39B-3,681.59%-7.2B25.11%294M16.86%305M-13.52%211M-31.46%941M-29.97%201M
Net income -0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B
Net income continuous Operations -0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B
Minority interest income
Net income attributable to the parent company -0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B
Basic earnings per share 0.00%0.9437.84%1.028.57%0.76133.84%7.67479.78%5.329514.63%0.94-6.33%0.74-6.67%0.7-16.75%3.2854.64%0.9192
Diluted earnings per share 0.00%0.9436.49%1.018.57%0.76134.36%7.64479.12%5.2714.63%0.94-5.13%0.74-6.67%0.7-16.62%3.2654.24%0.91
Dividend per share 7.27%0.597.27%0.597.27%0.597.84%2.27.84%0.557.84%0.557.84%0.557.84%0.558.51%2.048.51%0.51
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -